On Monday, RxSight Inc (NASDAQ: RXST) opened lower -4.93% from the last session, before settling in for the closing price of $26.56. Price fluctuations for RXST have ranged from $24.09 to $66.54 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 172.93% annually for the last half of the decade. Company’s average yearly earnings per share was noted 25.14% at the time writing. With a float of $38.38 million, this company’s outstanding shares have now reached $40.43 million.
In an organization with 498 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 65.95%, operating margin of -24.57%, and the pretax margin is -18.27%.
RxSight Inc (RXST) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of RxSight Inc is 5.20%, while institutional ownership is 87.21%. The most recent insider transaction that took place on Mar 12 ’25, was worth 180,002. In this transaction Director of this company sold 7,000 shares at a rate of $25.71, taking the stock ownership to the 24,793 shares. Before that another transaction happened on Mar 12 ’25, when Company’s Director proposed sale 7,000 for $25.71, making the entire transaction worth $180,002.
RxSight Inc (RXST) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.01 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 25.14% per share during the next fiscal year.
RxSight Inc (NASDAQ: RXST) Trading Performance Indicators
Check out the current performance indicators for RxSight Inc (RXST). In the past quarter, the stock posted a quick ratio of 10.50. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.31.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.71, a number that is poised to hit -0.20 in the next quarter and is forecasted to reach -0.27 in one year’s time.
Technical Analysis of RxSight Inc (RXST)
Let’s dig in a bit further. During the last 5-days, its volume was 0.54 million. That was inferior than the volume of 0.61 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 68.09%. Additionally, its Average True Range was 1.21.
During the past 100 days, RxSight Inc’s (RXST) raw stochastic average was set at 3.68%, which indicates a significant decrease from 38.16% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 53.65% in the past 14 days, which was higher than the 49.29% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $29.01, while its 200-day Moving Average is $43.19. However, in the short run, RxSight Inc’s stock first resistance to watch stands at $25.99. Second resistance stands at $26.73. The third major resistance level sits at $27.22. If the price goes on to break the first support level at $24.76, it is likely to go to the next support level at $24.27. The third support level lies at $23.52 if the price breaches the second support level.
RxSight Inc (NASDAQ: RXST) Key Stats
There are currently 40,491K shares outstanding in the company with a market cap of 1.02 billion. Presently, the company’s annual sales total 139,930 K according to its annual income of -27,460 K. Last quarter, the company’s sales amounted to 40,210 K and its income totaled -5,940 K.
